. Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol Renal Physiol 285: F694-F702, 2003. First published June 24, 2003 10.1152/ajprenal.00097.2003.-The deficiency of Npr1 [genetic determinant of natriuretic peptide receptor A (NPRA)] increases arterial pressures and causes hypertensive heart disease in mice similar to those seen in untreated human hypertensive patients. However, the quantitative role of NPRA in mediating the renal responses to blood volume expansion remains uncertain. To determine the specific contribution of NPRA in mediating the signaling mechanisms responsible for natriuretic and diuretic responses to nondilutional intravascular expansion, we administered whole blood to anesthetized Npr1 homozygous null mutant (0-copy), wild-type (2-copy), and gene-duplicated (4-copy) mice. In wild-type (2-copy) animals, urinary flow (l ⅐ min Ϫ1 ⅐ g kidney wt Ϫ1 ) increased from 4.9 Ϯ 1.0 to 14.4 Ϯ 1.8 and sodium excretion (eq ⅐ min Ϫ1 ⅐ g kidney wt Ϫ1 ) from 1.15 Ϯ 0.22 to 3.11 Ϯ 0.60, associated with a rise in glomerular filtration rate (GFR; ml ⅐ min Ϫ1 ⅐ g kidney wt Ϫ1 ) from 0.63 Ϯ 0.03 to 0.82 Ϯ 0.09 and renal plasma flow (RPF; ml ⅐ min Ϫ1 ⅐ g kidney wt Ϫ1 ) from 2.96 Ϯ 0.17 to 4.36 Ϯ 0.41, whereas arterial pressure did not significantly increase. After volume expansion, 0-copy mice showed significantly lesser increases in urinary flow (P Ͻ 0.001) and sodium excretory (P Ͻ 0.001) responses even though the increases in arterial pressures were greater (P Ͻ 0.001) compared with 2-copy mice. The 4-copy mice showed augmented responses in urinary flow (P Ͻ 0.01) and sodium excretion (P Ͻ 0.001) along with rises in both GFR (P Ͻ 0.01) and RPF (P Ͻ 0.01) compared with 2-copy wild-type mice. These results establish that NPRA activation is the predominant mechanism mediating the natriuretic, diuretic, and renal hemodynamic responses to acute blood volume expansion.
IN RESPONSE TO AN increase in atrial distension, the peptide hormone atrial natriuretic peptide (ANP) is released into the circulation and elicits natriuresis, diuresis, and vasodilation (8, 25) . Acting on natriuretic peptide receptors, ANP inhibits salt and water reabsorption in proximal tubule and inner medullary collecting duct cells and inhibits renin and vasopressin release as well as aldosterone synthesis and secretion (1, 4, 7, 47) .
Natriuretic peptides belong to a family of three homologous peptide hormones. ANP and brain natriuretic peptide (BNP) are released by the heart; and C-type natriuretic peptide (CNP) is produced in endothelial cells (10, 20, 46) . All three natriuretic peptides are thought to exert important roles in the maintenance of blood pressure and cardiovascular homeostasis. Distinct natriuretic peptide receptors have been identified and characterized by molecular cloning (39, 41) . These include natriuretic peptide receptor A, B, and C, also designated as NPRA, NPRB, and NPRC, respectively (11, 19, 33) . Both ANP and BNP specifically bind to NPRA, whereas CNP binds to NPRB; nevertheless, all three natriuretic peptides show affinity to NPRC. The hormone binding to NPRA and NPRB results in the production of intracellular second messenger cGMP by guanylyl cyclase activity that resides in the intracellular domains of these receptors (22, 36, 43) . NPRA is thought to be the primary ANP/BNP signaling molecule and has been suggested as the principal mediator of natriuretic peptide activities.
Previous experimental data established that ANP plays an important role in regulation of renal function by its vasodilatory and natriuretic responses and its ability to counteract the renin-angiotensin-aldosterone system in a tissue-specific manner (25) . Attempts have been made to define physiological responses of ANP using several experimental approaches. It has been possible to correlate the effects of changes in blood hormone levels commensurate with those found in pathophysiological states by infusing the exogenous hormones (40) . Cardiac appendectomy has been used to prevent ANP release; however, the problem in this setting is that the missing normal cardiac function results in a lack of physiological reflexes that are normally elicited by atria (42) . Other studies used monoclonal antibodies against circulating ANP and agents that specifically inhibit the signaling pathway of NPRA by blocking cGMP production. Although two com-pounds, A-71915 and HS-142-1, have been shown to diminish the effect of ANP by antagonizing NPRA, these compounds do not completely inhibit NPRA and may have nonspecific effects (9, 30) . Gene-targeting strategies in mice provide novel approaches in the study of the physiological responses corresponding to gene dosage in vivo (15, 45) .
Genetic mouse models with disruption of the ANP/ NPRA system have provided strong support for a physiological role of this hormone-receptor system in the regulation of arterial pressure and other pathophysiological functions (13, 14, 21, 24, 31, 37, 44) . Therefore, the genetic defects that reduce the activity of ANP and its receptor system can be considered as candidate contributors to essential hypertension and congestive heart failure (12, 14, 17, 18, 31, 44, 48) . To examine the regulatory role of NPRA in kidney function and blood pressure homeostasis at the molecular level, we performed studies evaluating the changes in renal function using Npr1 (coding for NPRA) gene-disrupted and gene-duplicated mutant mouse models. We hypothesized that the quantitative genetic alterations in NPRA expression levels in vivo mediate the primary ANP signaling mechanism responsible for the natriuretic and hemodynamic responses to intravascular expansion. To test this hypothesis, we administered whole blood to null homozygous mutant (0-copy), wildtype (2-copy), and gene-duplicated (4-copy) mice to produce intravascular volume expansion not accompanied by hemodilution.
MATERIALS AND METHODS
Generation of mice and genotyping. Npr1 gene-disrupted and gene-duplicated mice were generated by homologous recombination in embryonic stem cells as previously described (31, 32) . Animals were bred and maintained at the Animal Care Facility of Tulane University Health Sciences Center and handled under protocols approved by the Institutional Animal Care and Use Committee. Npr1 genotypes used in the present studies were littermate progenies of a mixed 129/C57BL6 genetic background and have been designated as follows: homozygous mutant allele (Ϫ/Ϫ; 0-copy), wild-type allele (ϩ/ϩ; 2-copy), and gene-duplicated allele (ϩϩ/ϩϩ; 4-copy). The breeding of 1-copy (ϩ/Ϫ) heterozygous animals generated progenies consisting of 0-, 1-, and 2-copy mice. These animals were genotyped by multiple PCR analysis of DNA isolated from tail biopsies using primer A (5Ј-GCT CTC TTG TCG CCG AAT CT-3Ј), corresponding to a sequence 5Ј to the mouse Npr1 gene common to both alleles (2-copy); primer B (5Ј-TGT CAC CAT GGT CTG ATC GC-3Ј), corresponding to an exon 1 sequence only present in the intact mouse allele (1-copy); and primer C (5Ј-GCT TCC TCG TGC TTT ACG GT-3Ј), a sequence in the neomycin resistance cassette only present in the null allele (0-copy). The PCR reaction from tail DNA included 50 mM Tris ⅐ HCl (pH 8.5), 20 mM ammonium sulfate, 1.5 mM MgCl 2, 10% DMSO, 100 M each of dNTPs, 2 U of Taq DNA polymerase, and 40 nM primers. The PCR for 0-, 1-, and 2-copy mice was performed by the use of a 60-s denaturation step at 94°C, a 60-s annealing step at 60°C, and 60-s extension step at 72°C, respectively, for 35 cycles using DNA Thermal Cycler 480 as previously described (44) with modifications. PCR products were resolved on 2% agarose gels with the endogenous band of 500 bp and targeted band of 200 bp (Fig. 1A) .
The breeding of gene-duplicated 3-copy (ϩϩ/ϩ) heterozygous mice generated progenies consisting of 2-, 3-, and 4-copy animals. The Npr1 gene-duplicated mice were genotyped using upstream (5Ј-CCT CTA GAT GCA TAC ATG TCG C-3Ј) and downstream (5Ј-GGT CAA GTT AAG TGT ATT TTT TTC CC-3Ј) primers. The PCR reaction from tail DNA included 10 mM Tris ⅐ HCl, pH 8.3, 50 mM KCl, 4 mM MgCl 2, 0.4 mM each of dNTPs, 2.5 U of Taq DNA polymerase, and 40 nM primers. The PCR was performed by the use of a 30-s denaturation step at 94°C, a 30-s annealing step at 60°C, and a 30-s extension step at 72°C, respectively, for 35 cycles as previously described (32) with modifications. The amplified genomic fragments were separated on nondenaturing acrylamide gels and corresponded to 108-and 124-bp bands from 2-and 4-copy genotypes, respectively, whereas the heterozygous (3-copy) animals contained both 108-and 124-bp amplified genomic fragments (Fig. 1B) .
Animal preparation. The mice were housed under a 12: 12-h light-dark cycle at 25°C and fed regular chow (Purina Laboratory) and tap water ad libitum. In the present experiments, 16-to 24-wk-old male mice weighing 30-35 g were used. Animals were anesthetized with Inactin (100 mg/kg ip thiobutabarbital sodium salt). A supplemental dosage of anesthetic (5 mg/kg im ketamine) was administered as required. The animals were placed on a servo-controlled surgi- cal table that maintained body temperature at 37°C, and a tracheotomy was performed. The animals were allowed to breathe humidified 95% O 2-5% CO2 by placing the exterior end of the tracheal cannula inside a small plastic chamber. The right jugular vein was catheterized with PE-10 tubing for fluid infusion. After catheterization, 0.9% NaCl containing 10% Inutest (Laevasom-Gesellschoft, Ling, Austria), 3% PAH (Sigma), and 1% BSA was infused at a rate of 2.5 l/min. The left carotid artery was cannulated (PE-10 tubing connected to PE-50 tubing) for measurements of arterial pressure. Blood pressures were recorded on a pressure transducer connected to a Grass polygraph (Grass Instrument, Quincy, MA). Blood pressures were determined continuously throughout the duration of the experiment. The bladder was catheterized with PE-50 tubing via a supra pubic incision for urinary collections as previously described (6) . After equilibration for 45 min, eight consecutive 20-min urinary collections were obtained. At the end of the experiment, blood was collected from the carotid artery into hematocrit tubes and chilled tubes containing 5 l of 0.2 M sodium-EDTA and was immediately centrifuged at 4°C. Plasma was removed and stored at Ϫ80°C until used to assay ANP, total protein content, Inutest, and PAH concentrations.
Volume expansion. Npr1 homozygous mutant (0-copy; n ϭ 9), wild-type (2-copy; n ϭ 9), and gene-duplicated (4-copy; n ϭ 9) mice received whole blood obtained from age-matched 1-copy (n ϭ 18) or 3-copy (n ϭ 9) male donor mice. The donor animals were anesthetized with Inactin (100 mg/kg ip), and the whole blood was drawn by cardiac puncture using a heparinized syringe. Hemodynamic and kidney functions were determined before (0-60 min), during (60-80 min), and after (80-160 min) blood volume expansion. Before the volume expansion period (0-60 min), three initial consecutive 20-min urine collections and blood pressure measurements were performed, after which the blood volume expansion was carried out beginning at 60 min. Fresh whole blood was infused into 0-, 2-, and 4-copy mice over a 20-min volume expansion period (60-80 min) to expand the circulating blood volume by an estimated 15% (450 l, ϳ1.5% of body wt). Five consecutive 20-min recovery (60-160 min) blood pressure measurements and urinary collections were performed during and after the blood infusion. One hundred microliters of blood were collected at 60 and 100 min, and total blood was collected at 160 min after the completion of the experiment.
Determination of plasma and urinary inulin (Inutest) and PAH. Ten microliters of plasma were mixed with 110 l of 3.2% TCA, centrifuged at 3,000 rpm for 30 min, and the supernatant was collected. Each 5 l of collected urine were diluted with 9.995 ml of water. For Inutest measurements, 25 l of TCA-precipitated plasma supernatant, diluted urine samples, or Inutest standards were added to a 96-well plate. Two hundred fifty microliters of 0.1% anthrone were added to each well, and samples were incubated at 60°C for 10 min. The plates were counted at 620-nm wavelength with a multiscan plate reader (Lab System, Franklin, MA). Similarly, for PAH measurement, 50-l samples and PAH standards were added to a 96-well plate. Simultaneously, water (150 l), 0.2 N HCl (40 l), 0.1% sodium nitrite (20 l), 0.5% ammonium sulfamate (20 l), and 0.1% N-(naphthyl) ethylenediamine (20 l) were added to each well. After each addition, the plate was shaken and then counted at 540 nm. Glomerular filtration rate (GFR) was calculated as urine-toplasma Inutest concentration ratio times urinary flow and was factored per gram kidney weight. Renal plasma flow (RPF) was calculated as urine-to-plasma PAH concentration ratio times urinary flow and was factored per gram kidney weight. The plasma protein concentrations of donor and recipient mice were determined in a 96-well plate using a Bio-Rad protein assay kit (Hercules, CA).
Analytic procedures. The hematocrit of each blood sample from donor or recipient mice was measured after centrifugation with Adams Autocrit. Urinary volumes were determined by gravimetry. The sodium and potassium concentrations of all samples were determined by flame photometry (model 443, Instrumentation Laboratory). Fractional sodium excretion was calculated by dividing the urine/plasma sodium concentration ratio by the urine/plasma Inutest ratio. Similarly, fractional potassium excretion was calculated by dividing the urine/plasma potassium concentration ratio by the urine/plama Inutest ratio.
Urinary cGMP assay. Ten microliters of acetylated urine samples were mixed with 90 l of 0.05 M sodium acetate buffer, pH 6.2, and cGMP in the samples was determined with a radioimmunoassay kit (Peninsula, Belmont, CA) as previously described (35) .
Plasma ANP assay. A plasma sample (400 l) was applied to Sep-Pak C-18 column that was prewashed with methanol and 0.1% trifluoroacetic acid (TFA). The column was washed with 5 ml of 0.1% TFA and eluted with a 3-ml mixture of methanol:water:TFA (80:19.9:0.1) as previously described (34, 44) . The eluates were brought to dryness in a speed vac centrifuge. The residues were dissolved into 100 mM Tris buffer, pH 7.5, containing 2.5 mM EDTA, 1 mM PMSF, 0.02% sodium azide, and 0.1% BSA. ANP was quantitated using ANP antibodies (Peninsula; 10,000ϫ dilution) and 125 I-ANP as previously described (38) . One hundred-microliter plasma samples were mixed with 100 l antibody at 4°C for 48 h, after which 100 l 125 I-ANP (15,000 cpm) were added and samples were incubated further for 24 h at 4°C. On day 4, 100 l (500-fold dilution) goat anti-rabbit immunoglobulin serum and 10 l (500-fold dilution) normal rabbit serum were added and mixed. After centrifugation at 1,500 g for 30 min at 4°C, the supernatant was aspirated and radioactivity in the pellet was counted with a gamma counter.
Statistical analyses. The results are presented as means Ϯ SE. Statistical analyses were performed by factorial one-way ANOVA followed by the Student-Newman-Keuls post hoc test for multiple comparisons (GraphPad Instat Software, GraphPad Software, San Diego, CA). For all tests, statistical significance was set at P Ͻ 0.05.
RESULTS
Urinary cGMP and plasma ANP concentrations. As shown in Fig. 2 , before volume expansion, urinary cGMP excretion rates (pmol ⅐ min Ϫ1 ⅐ g kidney
Ϫ1
) were significantly lower in 0-copy mice (3.5 Ϯ 0.9; P Ͻ 0.05) and significantly higher in 4-copy mice (14.7 Ϯ 1.3; P Ͻ 0.05) compared with 2-copy wild-type mice (7.6 Ϯ 1.0). Interestingly, during volume expansion, urinary cGMP excretion rates were dramatically increased in both 2-and 4-copy mice; however, the cGMP values were significantly higher in 4-copy mice (27.8 Ϯ 2.1; P Ͻ 0.01) compared with 2-copy wild-type animals (14.2 Ϯ 1.9). On the other hand, the urinary cGMP excretion rate was significantly reduced in 0-copy mice (1.0 Ϯ 0.05; P Ͻ 0.01). After volume expansion, the urinary cGMP excretion rates were 0.7 Ϯ 0.1, 3.6 Ϯ 1.6, and 10.5 Ϯ 2.0 in 0-, 2-, and 4-copy mice, respectively. Figure 3 shows that after volume expansion, the plasma ANP concentrations (pmol/ml) were significantly higher in 0-copy mice (2.5 Ϯ 0.2; P Ͻ 0.01) compared with 2-copy (1.5 Ϯ 0.2) and 4-copy (0.7 Ϯ 0.1) mice, respectively.
Plasma protein concentrations and hematocrits. The plasma protein concentrations were not significantly different among either donor (1-and 3-copy) or recipient (0-, 2-, and 4-copy) mice (Fig. 4A) . Similarly, there were no significant differences in hematocrits in the donor mice. However, after volume expansion, the hematocrits in recipient 2-and 4-copy mice were significantly higher compared with recipient 0-copy mice (Fig. 4B) .
Mean arterial blood pressures before, during, and after whole blood volume expansion. The mean arterial pressures during all conditions were 30-40 mmHg higher in Npr1 homozygous null mutant (0-copy) mice than in wild-type (2-copy) mice (Fig. 5) . In contrast, the mean arterial pressures were 15-20 mmHg lower in Npr1 gene-duplicated (4-copy) mice than in wild-type (2-copy) control animals. Before volume expansion (0-60 min), the mean arterial pressures (mmHg) were significantly higher in 0-copy mice (129 Ϯ 4; P Ͻ 0.001) and significantly lower in 4-copy mice (77 Ϯ 2; P Ͻ 0.01) compared with 2-copy wild-type mice (92 Ϯ 3). During volume expansion (60-80 min), the mean arterial pressures increased and remained at significantly higher levels in 0-copy mice (140 Ϯ 4; P Ͻ 0.001) but remained at significantly lower levels in 4-copy mice (90 Ϯ 3; P Ͻ 0.01) compared with 2-copy wild-type mice (108 Ϯ 3). Even after volume expansion (80-160 min), the mean arterial pressures remained at significantly higher levels in 0-copy mice (136 Ϯ 4; P Ͻ 0.001) and at significantly lower levels in 4-copy mice (81 Ϯ 3; P Ͻ 0.01) compared with 2-copy wild-type animals (95 Ϯ 4). GFR and RPF. As shown in Fig. 6A , before volume expansion, the baseline (0-60 min) GFR (ml ⅐ min Ϫ1 ⅐ g kidney wt
) was significantly lower in 0-copy mice (0.49 Ϯ 0.03; P Ͻ 0.05) and significantly higher in 4-copy mice (0.81 Ϯ 0.04; P Ͻ 0.05) compared with 2-copy wild-type counterparts (0.63 Ϯ 0.03). During the Fig. 2 . Effect of volume expansion on urinary cGMP excretion in Npr1 homozygous null mutant (0-copy; n ϭ 9), wild-type (2-copy; n ϭ 9), and gene-duplicated (4-copy; n ϭ 9) mice. Blood volume expansion was administered for a 20-min period (between 60 and 80 min). Urine was collected at each 20-min interval throughout the entire duration of the experiment (0-160 min). The contents of cGMP in urinary samples were determined by radioimmunoassay. KW, kidney weight. *P Ͻ 0.05; **P Ͻ 0.01. Fig. 3 . Effect of volume expansion on plasma atrial natriuretic peptide (ANP) levels in Npr1 homozygous mutant (0-copy), wild-type (2-copy), and gene-duplicated (4-copy) mice. Blood was collected from the cannulated carotid artery at the end of the volume expansion experiment. Plasma was separated and ANP levels were determined by radioimmunoassay. The number of animals used in each experiment is indicated within the vertical bars (n ϭ 9). *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001. volume expansion period, GFR increased in all groups, which was maintained at a significantly lower level in 0-copy mice (0.58 Ϯ 0.04; P Ͻ 0.01) and at a significantly higher level in 4-copy mice (1.19 Ϯ 0.12; P Ͻ 0.01) compared with 2-copy wild-type animals (0.82 Ϯ 0.09). Nevertheless, after volume expansion, GFR still remained at a significantly lower level in 0-copy mice (0.49 Ϯ 0.05; P Ͻ 0.05) and at a significantly higher level in 4-copy mice (0.87 Ϯ 0.08; P Ͻ 0.05) compared with 2-copy wild-type counterparts (0.68 Ϯ 0.06).
Similarly, as shown in Fig. 6B , the baseline RPF (ml ⅐ min Ϫ1 ⅐ g kidney wt Ϫ1 ) was significantly lower in 0-copy mice (2.24 Ϯ 0.41; P Ͻ 0.05) and significantly higher in 4-copy mice (4.00 Ϯ 0.49; P Ͻ 0.05) compared with 2-copy wild-type animals (2.96 Ϯ 0.17). During volume expansion, the RPF remained at a significantly lower level in 0-copy mice (2.72 Ϯ 0.37; P Ͻ 0.01) and increased significantly in 4-copy mice (5.78 Ϯ 0.50; P Ͻ 0.01) compared with 2-copy wild-type control mice (4.36 Ϯ 0.41). Again, after volume expansion, the RPF was lower in 0-copy mice (2.29 Ϯ 0.30; P Ͻ 0.05) and remained significantly elevated in 4-copy mice (4.48 Ϯ 0.47; P Ͻ 0.05) compared with 2-copy wild-type animals (3.10 Ϯ 0.34).
Urinary flow and urinary sodium and potassium excretion. During volume expansion, urinary flow (l ⅐ min Ϫ1 ⅐ g kidney wt Ϫ1 ) in 2-copy animals increased from 4.9 Ϯ 1.0 to 14.4 Ϯ 1.8 and sodium excretion rate (eq ⅐ min Ϫ1 ⅐ g kidney wt
) from 1.15 Ϯ 0.22 to 3.11 Ϯ 0.60 (Fig. 7, A and B) . In contrast, 0-copy animals exhibited only a small change in urinary flow (3.4 Ϯ 0.2 to 5.0 Ϯ 1.0; P Ͻ 0.001) and sodium excretion (0.69 Ϯ 0.21 to 1.10 Ϯ 0.18; P Ͻ 0.001) despite the greater increases in arterial pressures. Interestingly, 4-copy mice showed significantly higher urinary flow (6.5 Ϯ 0.6 to 24.0 Ϯ 2.5; P Ͻ 0.01) and sodium excretion (1.86 Ϯ 0.23 to 4.75 Ϯ 0.60; P Ͻ 0.01) compared with 2-copy control animals (Fig. 7, A and B) . Even after volume expansion, both 2-and 4-copy mice had significantly higher urinary flows and sodium excretion rates compared with 0-copy mice. In contrast, urinary potassium excretion rates were not significantly different in any of the Npr1 genotypes before, during, and after volume expansion and were not increased by blood volume expansion (Fig. 7C) .
As shown in Fig. 8 , before volume expansion, the percent baseline fractional sodium excretions remained at a significantly lower level in 0-copy mice (0.76 Ϯ 0.14%) and were not significantly different in 4-copy (1.51 Ϯ 0.14%) mice compared with 2-copy (1.32 Ϯ 0.13%) wild-type mice. However, during volume expansion, fractional sodium excretions were significantly elevated in 4-copy mice (3.65 Ϯ 0.22%; P Ͻ 0.01) and remained significantly lower in 0-copy mice (1.23 Ϯ 0.16%; P Ͻ 0.01) compared with 2-copy wildtype animals (2.45 Ϯ 0.16%). After volume expansion, fractional sodium excretions were still significantly higher in 2-copy (1.64 Ϯ 0.16%) and 4-copy (1.90 Ϯ 0.18%) mice compared with 0-copy mice (1.14 Ϯ 0.15%). No significant differences in fractional potassium excretions were observed among the three groups of Npr1 mice (data not shown).
DISCUSSION
The present study examined the role of NPRA in the renal and arterial pressure responses to blood volume expansion in Npr1 homozygous null mutant (0-copy), wild-type (2-copy), and gene-duplicated (4-copy) mice. The Npr1 gene-disrupted (0-copy) mice showed the Fig. 5 . Effect of volume expansion on mean blood pressures in Npr1 homozygous mutant (0-copy; n ϭ 9), wild-type (2-copy; n ϭ 9), and gene-duplicated (4-copy; n ϭ 9) mice. Mean blood pressures measured by cannulated carotid arterial methods were continuously recorded for 160 min throughout the duration of the experiment. **P Ͻ 0.01; ***P Ͻ 0.001. Fig. 6 . Effect of volume expansion (VE) on glomerular filtration rate (GFR; A) and renal plasma flow (RPF; B) in Npr1 null mutant (0-copy; n ϭ 9), wild-type (2-copy; n ϭ 9), and gene-duplicated (4-copy; n ϭ 9) mice. Both GFR and RPF were measured in 3 consecutive periods at before (0-60 min), during (60-80 min), and after (80-160 min) pure blood VE. *P Ͻ 0.05; **P Ͻ 0.01. highest blood pressures, whereas the Npr1 gene-duplicated (4-copy) mice had the lowest blood pressures compared with wild-type (2-copy) mice. During the period of volume expansion with whole blood infusion, the mean arterial blood pressures increased in all three genotypes; however, the mean arterial pressures were always significantly lower in 4-copy mice and significantly higher in 0-copy mice compared with 2-copy animals. Because of the slow infusion rate, the changes in arterial pressure in response to blood volume expansion were modest, although they appeared to be slightly greater in 2-and 4-copy mice. The renal hemodynamic function was different in the three groups. GFR was 25 to 35% lower in 0-copy mice and 30 to 45% higher in gene-duplicated (4-copy) mice compared with 2-copy wild-type control mice. Similarly, RPF was 25 to 30% lower in 0-copy mice and 45 to 70% higher in 4-copy mice compared with 2-copy control animals. It is noteworthy that 4-copy mice had higher GFR and RPF values during the volume expansion period, whereas 0-copy mice showed significantly lower GFR or RPF responses to the volume expansion. Furthermore, during the volume expansion, 2-copy wild-type animals exhibited significantly higher urinary flow and sodium excretory responses compared with 0-copy null mutant mice despite the greater mean arterial pressures in the 0-copy mice. Interestingly, 4-copy mice showed even greater urinary flow and sodium excretory responses than 2-copy mice. Urinary potassium excretion rates were not significantly different among three Npr1 genotypes before, during, or after volume expansion.
A number of factors influence the kidney's ability to excrete sodium and water in response to blood volume expansion (2, 3, 23, 27, 28) . Activation of natriuretic systems such as natriuretic peptides (ANP, BNP) and nitric oxide enhances the pressure-natriuresis relationship and reduces arterial pressures. It has also been suggested that chloride-mediated feedback control of NPRA occurs in the kidney and probably plays a role in the regulation of ANP-mediated natriuresis (26) . Initial studies have shown that ANP suppresses renin and decreases blood pressures (5, 24, 29) . Our earlier findings with Npr1 gene-disrupted mice demonstrated that, at birth, the absence of NPRA allows greater renin and ANG II levels and increased renin mRNA expression compared with 2-copy control mice (44) . However, at 3-16 wk of age, both circulating and kidney renin and ANG II levels were decreased dramatically in 0-copy mice compared with 2-copy control animals. This decrease in the renin activity in adult 0-copy mice could be due to progressive elevation in arterial pressures leading to inhibition of renin synthesis and release from the kidney juxtaglomerular cells. However, aldosterone levels in 0-copy mice were dissociated from the circulating ANG II levels and were elevated. It is also possible that the renin in 0-copy mice might be suppressed as a consequence of aldosterone-mediated sodium retention with associated fluid retention (44) . These and other various systems could be responsible for the differences in basal values among the three groups.
Previous studies suggested that increased levels of ANP released into the plasma in response to blood volume expansion in rats were mainly responsible for the natriuretic and diuretic responses (3, 4, 40) . Fur- Fig. 8 . Effect of VE on fractional sodium excretion in Npr1 homozygous mutant (0-copy; n ϭ 9), wild-type (2-copy; n ϭ 9), and geneduplicated (4-copy; n ϭ 9) mice. *P Ͻ 0.05; **P Ͻ 0.01. Fig. 7 . Effect of volume expansion on urinary flow (A), urinary sodium excretion (B), and urinary potassium excretion (C) in Npr1 homozygous mutant (0-copy; n ϭ 9), wild-type (2-copy; n ϭ 9), and gene-duplicated (4-copy; n ϭ 9) mice. Pure blood volume expansion was administered in a 20-min period (60-80 min). Urinary volume was collected at a 20-min period throughout the entire duration of the 160-min experiment at before, during, and after volume expansion. *P Ͻ 0.05; **P Ͻ 0.01; ***P Ͻ 0.001. thermore, Paul et al. (40) showed that both ANP and acute blood volume expansion act on the kidney through a similar saturable mechanism. However, direct evidence demonstrating the quantitative contribution of ANP working through NPRA to the natriuresis and diuresis resulting from an isohemic, isooncotic blood volume expansion has not been obtained. In a study using Npr1 homozygous null mutant and wildtype mice, it was demonstrated that infusion of ANP, while causing substantial natriuresis and diuresis in wild-type mice, did not cause significant increases in sodium excretion or urinary flow in NPRA-deficient mice (16) . Furthermore, urinary flow and sodium excretion rapidly increased in response to volume expansion with albumin containing Ringer solution in wildtype (2-copy) mice compared with homozygous null mutant (0-copy) mice. In the present study, we examined the quantitative contribution and possible mechanisms mediating the responses of NPRA by determining the RPF, GFR, urinary flow, and sodium and potassium excretion patterns following blood volume expansion in 0-, 2-, and 4-copy mice in a Npr1 gene dose-dependent manner. By using whole blood, hemodilution did not occur and plasma protein levels were not reduced. Thus other natriuretic mechanisms related to plasma dilution, such as decreases in colloid osmotic pressure or decreases in hematocrit, were not activated with this protocol. Although the blood volume expansion stimulated the release of ANP in all three Npr1 genotypes of mice, significant functional responses occurred only in 2-and 4-copy mice but not in 0-copy animals. These results demonstrate that the ANP/NPRA axis is primarily responsible for mediating the renal hemodynamic and sodium excretion responses to intravascular blood volume expansion. Furthermore, the sodium excretion responses appear to be due to the combined contribution of increases in filtered load as well as reductions in tubular fractional reabsorption. The associated changes in urinary cGMP excretion rates are consistent with the activation of tubular NPRA leading to increased formation of cGMP, which might pass into tubular fluid and be excreted in the urine. In addition, it should be noted that the increase in urinary flow could be due, in part, to an inhibition of antidiuretic hormone levels via the lowpressure volume receptors stimulated by intravascular volume expansion.
The finding that the absence of NPRA almost completely prevented the sodium excretory responses to blood volume expansion is somewhat surprising in that there are multiple systems that respond to volume expansion. An important part of the experimental design was to minimize nonspecific responses that could be associated with hemodilution, reductions in plasma colloid osmotic pressure, and other compositional changes in the blood that could directly affect sodium reabsorption and/or GFR. In addition, the blood volume infusion period was extended over a 20-min period to minimize reflexogenic alterations in sympathetic tone and volume expansion-mediated inhibition of vasopressin release. In this setting, it was possible to demonstrate the critical role that NPRA exerts in mediating the sodium excretory responses to a selective stimulus associated with blood volume expansion, which is presumably due to increases in right atrial pressure caused by the blood infusion.
Earlier studies suggested that the ANP/NPRA system plays an important role in blood pressure homeostasis by direct natriuretic, diuretic, and vasodilatory actions on the kidneys (4, 25) . ANP-deficient genetic strains of mice demonstrated that a defect in ANP synthesis can cause hypertension in homozygous null mutant mice with no circulating or cardiac ANP (14) . Therefore, genetic defects that reduce the activity of the natriuretic peptide system can be considered as candidate contributors to essential hypertension. Mice lacking the ANP gene function and kept on a high-salt diet (8% NaCl) showed hypertension with increased arterial pressures of ϳ22 mmHg, which suggested that genetically reduced production of ANP can lead to salt-sensitive hypertension (14) . Npr1 gene-deficient mice used in the present study exhibited a higher mean arterial pressure on high-salt diet compared with animals kept on medium-or low-salt diets (32) . The absence of NPRA expression in 0-copy mice provoked salt-sensitive increases in blood pressures, whereas an increased expression of NPRA in 4-copy mice was able to lower the blood pressures and protected against high dietary salt intake. These previous studies provide evidence that ANP can be considered a major system contributing an important role in the regulation of blood volume and altered blood pressure. However, it should be acknowledged that Lopez et al. (21) failed to show salt-sensitive hypertension in their Npr1 genedeficient mice. Thus it is likely that ANP/NPRA axis induces hemodynamic and excretory parameters including sodium excretion, which reduces the intravascular fluid volume and is thus responsible for the decreased blood pressures observed in gene-duplicated (4-copy) mice. Our data demonstrate that ANP/NPRA axis serves an important mediator in acute natriuresis and diuresis after blood volume expansion.
In conclusion, our present results demonstrate that both GFR and RPF were significantly lower in 0-copy and higher in 4-copy mice compared with 2-copy wildtype animals before, during, and after volume expansion. The data show that ANP responses to volume expansion led to the significantly lesser excretion of sodium and water in 0-copy mice and significantly greater excretory responses along with reduced tubular reabsorption in 4-copy mice compared with 2-copy (wild type) mice. Similarly, during the volume expansion, urinary cGMP concentration was significantly lower in 0-copy mice and greater in 4-copy mice compared with 2-copy control animals. Thus the higher cGMP concentrations in urinary samples were increased corresponding to Npr1 gene copy numbers. Our findings establish that NPRA is critical in mediating the natriuresis, diuresis, and renal hemodynamic responses to acute blood volume expansion.
